Search Within

Jamie Erin Chaft

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (15)
  3. Research Letter (1)
Groups
  1. Department of Medicine (41)
  2. GSK Faculty (41)
  3. Human Oncology and Pathogenesis Program (41)
  4. Solid Tumor Oncology Division (41)
  5. Thoracic Oncology (41)
  6. Department of Pathology and Laboratory Medicine (39)

More Groups

People
  1. Marc Ladanyi (33)
  2. Mark Kris (31)
  3. Gregory Riely (23)
  4. Maria Arcila (19)
  5. Matthew Hellmann (15)
  6. Charles Rudin (14)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (4)
  3. Clinical Cancer Research (3)
  4. Modern Pathology (3)
  5. Laboratory Investigation (2)
  6. Molecular Cancer Therapeutics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (7)
  3. Elsevier Inc. (5)
  4. Nature Publishing Group (4)
  5. Nature Research (3)
  6. American Medical Association (2)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of the KRAS/EGFR mutation profile and survival of "collegiate smokers" and never smokers with advanced lung cancers
    Meeting Abstract

    Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Janjigian, Y. Y.; Drilon, A. E. D.; Yu, H. A.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • EGFR exon 20 insertion mutations: Incidence and clinicopathologic characteristics in US patients with lung adenocarcinoma
    Meeting Abstract

    Arcila, M. E.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas
    Journal Article

    Arcila, M. E.; Chaft, J. E.; Nafa, K.; Roy Chowdhuri, S.; Lau, C.; Zaidinski, M.; Paik, P. K.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Molecular and clinicopathologic characteristics of HER2 mutant lung adenocarcinoma (ADC)
    Meeting Abstract

    Chowdhuri, S. R.; Chaft, J.; Nafa, K.; Kris, M.; Zakowski, M.; Ladanyi, M.; Arcila, M.
    Modern Pathology (2012)

    Fulltext@MSK | Save
  • Molecular and clinicopathologic characteristics of HER2 mutant lung adenocarcinoma (ADC)
    Meeting Abstract

    Chowdhuri, S. R.; Chaft, J.; Nafa, K.; Kris, M.; Zakowski, M.; Ladanyi, M.; Arcila, M.
    Laboratory Investigation (2012)

    Fulltext@MSK | Save
  • ALK-rearranged lung cancer: Adenosquamous lung cancer masquerading as pure squamous carcinoma
    Journal Article

    Chaft, J. E.; Rekhtman, N.; Ladanyi, M.; Riely, G. J.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling
    Journal Article

    Chaft, J. E.; Arcila, M. E.; Paik, P. K.; Lau, C.; Riely, G. J.; Pietanza, M. C.; Zakowski, M. F.; Rusch, V.; Sima, C. S.; Ladanyi, M.; more...
    Molecular Cancer Therapeutics (2012)

    Fulltext@MSK | Save
  • Clinical, pathologic, and molecular characteristics of patients with non-small cell lung cancer harboring mutations in PIK3CA
    Meeting Abstract

    Pietanza, M. C.; Arcila, M. E.; Chaft, J. E.; Zakowski, M. F.; Ladanyi, M.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Incorporation of crizotinib into the NCCN guidelines
    Journal Article

    Riely, G. J.; Chaft, J. E.; Ladanyi, M.; Kris, M. G.
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save